graduation at Iniciação Científica from Instituto Adolfo Lutz (2022) and graduation at Ciências Biológicas from Instituto Federal de São Paulo (2022). , acting on the following subjects: anti-trypanosomal activity, olefin cross metathesis, trypanosoma cruzi, dehydrodieugenol and ruthenium. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Comprising a vast chemodiversity, bacteria isolated from the marine microbiome have been gaining attention in the pharmaceutical field, providing unprecedented secondary metabolites as drug prototypes. Among the neglected diseases of great relevance to WHO is Chagas disease, which affects 8 million people worldwide. With only a single drug approved in Brazil with high therapeutic failure …
Chagas disease affects about 8 million people, with only one drug approved in Brazil. Considering the therapeutic limitations of this protozoa, as well as the lack of interest from the private sector in investing in new therapies, there is a need for research into new drugs. Comprising a vast chemodiversity, marine microbial metabolites are one of the important sources of new anti-infecti…
| 1 / 1 | Ongoing scholarships in Brazil |
| 2 / 2 | Completed scholarships in Brazil |
| 3 / 3 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID